Tracy Woody
Directeur/Bestuurslid bij ESPERION THERAPEUTICS, INC.
Vermogen: 72 503 $ op 31-05-2024
Momenteel actieve connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Sheldon Koenig | M | 58 | 4 jaar | |
| R. Clifton | M | 51 | 9 jaar | |
| Orlaith Ryan | F | - |
Shorla Pharma Ltd.
 Shorla Pharma Ltd. Pharmaceuticals: MajorHealth Technology Shorla Pharma Ltd. manufactures drugs in the oncology space for women’s and pediatric cancers. Its products include SH-111. The company was founded by Sharon Cunningham and Orlaith Ryan in 2018 and is headquartered in Clonmel, Ireland. | 6 jaar |
| Sharon Cunningham | F | - |
Shorla Pharma Ltd.
Shorla Pharma Ltd. Pharmaceuticals: MajorHealth Technology Shorla Pharma Ltd. manufactures drugs in the oncology space for women’s and pediatric cancers. Its products include SH-111. The company was founded by Sharon Cunningham and Orlaith Ryan in 2018 and is headquartered in Clonmel, Ireland. | 6 jaar |
| Marianne Andreach | F | - | - | |
| J. Carroll | M | 74 | 2 jaar | |
| Sarah O'Dowd | F | 74 | 4 jaar | |
| Benjamin Looker | M | 42 | 2 jaar | |
| Stephen Rocamboli | M | 52 | 2 jaar | |
| Jay Shepard | M | 66 | 6 jaar | |
| Nicole Vitullo | F | 66 | 16 jaar | |
| Antonio Gotto | M | 88 | 10 jaar | |
| Benjamin Halladay | M | 38 | 4 jaar | |
| Alan Fuhrman | M | 67 | 4 jaar | |
| Eric Warren | M | 76 | 3 jaar | |
| JoAnne Foody | M | 59 | 3 jaar | |
| Alexis Callahan | M | - | - | |
| Asif Ali | M | 50 | 2 jaar | |
| Alan O'Connell | M | - |
Shorla Pharma Ltd.
Shorla Pharma Ltd. Pharmaceuticals: MajorHealth Technology Shorla Pharma Ltd. manufactures drugs in the oncology space for women’s and pediatric cancers. Its products include SH-111. The company was founded by Sharon Cunningham and Orlaith Ryan in 2018 and is headquartered in Clonmel, Ireland. | - |
| Rene A. Braeckman | M | - | 8 jaar | |
| Victoria Power | F | - |
Shorla Pharma Ltd.
Shorla Pharma Ltd. Pharmaceuticals: MajorHealth Technology Shorla Pharma Ltd. manufactures drugs in the oncology space for women’s and pediatric cancers. Its products include SH-111. The company was founded by Sharon Cunningham and Orlaith Ryan in 2018 and is headquartered in Clonmel, Ireland. | - |
| Tom Brennan | M | - |
Shorla Pharma Ltd.
Shorla Pharma Ltd. Pharmaceuticals: MajorHealth Technology Shorla Pharma Ltd. manufactures drugs in the oncology space for women’s and pediatric cancers. Its products include SH-111. The company was founded by Sharon Cunningham and Orlaith Ryan in 2018 and is headquartered in Clonmel, Ireland. | - |
| Glenn Brame | M | 67 | 1 jaar | |
| Seth Fischer | M | 68 | 3 jaar | |
| John Moloney | M | 69 |
Shorla Pharma Ltd.
Shorla Pharma Ltd. Pharmaceuticals: MajorHealth Technology Shorla Pharma Ltd. manufactures drugs in the oncology space for women’s and pediatric cancers. Its products include SH-111. The company was founded by Sharon Cunningham and Orlaith Ryan in 2018 and is headquartered in Clonmel, Ireland. | 4 jaar |
| Harcharan Singh | M | 73 |
Shorla Pharma Ltd.
Shorla Pharma Ltd. Pharmaceuticals: MajorHealth Technology Shorla Pharma Ltd. manufactures drugs in the oncology space for women’s and pediatric cancers. Its products include SH-111. The company was founded by Sharon Cunningham and Orlaith Ryan in 2018 and is headquartered in Clonmel, Ireland. | - |
| Matthew M. Gosling | M | 53 | 4 jaar | |
| Betty Jean | F | - | 3 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Joshua Brumm | M | 46 |
Versartis, Inc.
 Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | 4 jaar |
| Gail McIntyre | M | 61 | 6 jaar | |
| Robert Hoffman | M | 58 |
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | 2 jaar |
| Eric Zhang | M | 43 |
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | 5 jaar |
| Edmon R. Jennings | M | 75 |
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | 6 jaar |
| Tim Mayleben | M | 63 | 11 jaar | |
| Amato Giaccia | M | 65 |
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | 6 jaar |
| Dov Goldstein | M | 56 | 11 jaar | |
| Donald Kalkofen | M | 60 | 3 jaar | |
| Rick Bartram | M | 63 | 9 jaar | |
| Shane Ward | M | 49 |
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | 3 jaar |
| Jeffrey Berkowitz | M | 58 | 6 jaar | |
| Daniel Cohen | M | 65 | 2 jaar | |
| Chaitan Khosla | M | 59 | 6 jaar | |
| Mark L. Smythe | M | - | 16 jaar | |
| Colin Hislop | M | 66 |
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | 1 jaar |
| Tony Sun | M | 52 |
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | 5 jaar |
| Mark E. McGovern | M | 70 | 8 jaar | |
| Daniel Janney | M | 58 | 9 jaar | |
| David Tierney | M | 60 | - | |
| R. Greer | M | 65 |
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | 4 jaar |
| Kenneth Lee | M | 76 |
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | - |
| Jami Taylor | M | - | 2 jaar | |
| John Varian | M | 64 |
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | 4 jaar |
| Scott Braunstein | M | 60 | 5 jaar | |
| Kevin Haas | M | 59 |
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | 4 jaar |
| Robert Gut | M | 59 |
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | 1 jaar |
| Patric Nelson | M | - | 5 jaar | |
| Paula O’Connor | M | - | - | |
| Gene Kim | M | 48 |
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | 5 jaar |
| Ben Church | M | - | 3 jaar | |
| Ken Fiorelli | M | - | 3 jaar | |
| Regina Cavaliere | F | - | - | |
| David Burke | M | - |
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | - |
| Vicky Gunvalson | F | - |
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | - |
| Andrew Barrett | M | - | 6 jaar | |
| Eric Dobmeier | M | 55 |
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | 1 jaar |
| Jay Stout | M | 61 |
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | - |
| Matthew Casbon | M | - | - | |
| Alexander Duke Schwartz | M | - | 2 jaar | |
| Paul B. Westberg | M | 56 | 1 jaar | |
| Scott Plevy | M | - | 3 jaar | |
| Mark Glickman | M | 58 | 2 jaar | |
| Vinay Shah | M | 62 | 4 jaar | |
| Jonathan Leff | M | 55 | 1 jaar | |
| Raymond Tabibiazar | M | 53 |
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | - |
| Keith L. Lui | M | - |
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | 3 jaar |
Statistieken
| Land | Connecties | % van het totaal |
|---|---|---|
| Verenigde Staten | 68 | 90.67% |
| Ierland | 7 | 9.33% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Tracy Woody
- Persoonlijk netwerk
